Lonza CEO Pierre-Alain Ruffieux to Leave
Lonza CEO Pierre-Alain Ruffieux to Leave
Read moreLonza CEO Pierre-Alain Ruffieux to Leave
Read moreUpdated Sept. 9, 2023 10:51 am ETVivek Ramaswamy was a novice biotech entrepreneur in 2016 with ...
Read moreText size Johnson & Johnson Benadryl brand allergy medication is now a part of Kenvue. Daniel ...
Read moreText size Rivian Automotive saw its cash and cash equivalents decline by $6.6 billion last year. ...
Read moreResume Subscription We are delighted that you'd like to resume your subscription. You will be charged ...
Read moreText size Johnson & Johnson took the Kenvue consumer-health business public in May. Mark Ralston/Getty Images ...
Read moreText size The Johnson & Johnson campus in Irvine, California. Mario Tama/Getty Images It’s crunchtime for ...
Read moreText size Cano posted a second-quarter net loss of $270.7 million. Stephen Zenner/Getty Images Cano Health ...
Read moreMany individual investors are trying to do that by purchasing 99 shares of Johnson & Johnson ...
Read moreText size Analysts project that Mounjaro will be the best-selling drug of all time. Dreamstime Sales ...
Read more